Neurological Masquerades of Diffuse Large B-cell Lymphoma: A Case Mimicking Motor Neurone Disease

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL) and typically presents with lymphadenopathy, constitutional symptoms, or extranodal disease.Neurological presentations are uncommon and may mimic primary neurological disorders, which creates significant diagnostic challenges.A 67-year-old woman presented with progressive lower back pain, paraesthesia affecting all four limbs that left her bed-bound, faecal incontinence, dysphagia, weight loss, and evolving neurological deficits, including left-sided facial weakness and asymmetric tetraparesis predominantly affecting the left side.Initial neuroimaging demonstrated no acute intracranial pathology and no evidence of spinal cord compression.Electromyography (EMG) revealed widespread active and chronic denervation, which suggested an anterior horn cell disorder or motor neurone disease (MND).However, the presence of sensory symptoms, constitutional features, and progressive clinical deterioration prompted further investigation.CT of the chest, abdomen, and pelvis identified cervical and retroperitoneal lymphadenopathy.Ultrasound-guided lymph node biopsy confirmed DLBCL.Cerebrospinal fluid (CSF) analysis did not demonstrate definitive evidence of central nervous system (CNS) lymphoma.After six cycles of polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisolone (Pola-R-CHP), the patient achieved complete metabolic remission and showed substantial improvement in her neurological symptoms.This case highlights the importance of maintaining a broad differential diagnosis in patients presenting with atypical neurological syndromes.DLBCL may rarely present with neurological features that mimic MND.Although a definitive paraneoplastic neurological syndrome (PNS) could not be established, a possible paraneoplastic neurological process was considered.Recognition of systemic red-flag features, such as weight loss and lymphadenopathy, was pivotal in reaching the correct diagnosis.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-10-27
DOI
https://doi.org/10.7759/cureus.118661
Primary Topic
CNS Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neurological Masquerades of Diffuse Large B-cell Lymphoma: A Case Mimicking Motor Neurone Disease

Habib Ullah Abir, Ibnul Shams, Rayhanul I Tuhin, Md Romman Khan
2 links
Cureus
CNS Lymphoma Diagnosis and Treatment
article

Neurological Masquerades of Diffuse Large B-cell Lymphoma: A Case Mimicking Motor Neurone Disease

Habib Ullah Abir, Ibnul Shams, Rayhanul I Tuhin, Md Romman Khan
article en

Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma (NHL) and typically presents with lymphadenopathy, constitutional symptoms, or extranodal disease.Neurological presentations are uncommon and may mimic primary neurological disorders, which creates significant diagnostic challenges.A 67-year-old woman presented with progressive lower back pain, paraesthesia affecting all four limbs that left her bed-bound, faecal incontinence, dysphagia, weight loss, and evolving neurological deficits, including left-sided facial weakness and asymmetric tetraparesis predominantly affecting the left side.Initial neuroimaging demonstrated no acute intracranial pathology and no evidence of spinal cord compression.Electromyography (EMG) revealed widespread active and chronic denervation, which suggested an anterior horn cell disorder or motor neurone disease (MND).However, the presence of sensory symptoms, constitutional features, and progressive clinical deterioration prompted further investigation.CT of the chest, abdomen, and pelvis identified cervical and retroperitoneal lymphadenopathy.Ultrasound-guided lymph node biopsy confirmed DLBCL.Cerebrospinal fluid (CSF) analysis did not demonstrate definitive evidence of central nervous system (CNS) lymphoma.After six cycles of polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisolone (Pola-R-CHP), the patient achieved complete metabolic remission and showed substantial improvement in her neurological symptoms.This case highlights the importance of maintaining a broad differential diagnosis in patients presenting with atypical neurological syndromes.DLBCL may rarely present with neurological features that mimic MND.Although a definitive paraneoplastic neurological syndrome (PNS) could not be established, a possible paraneoplastic neurological process was considered.Recognition of systemic red-flag features, such as weight loss and lymphadenopathy, was pivotal in reaching the correct diagnosis.

Cureus
United Lincolnshire Hospitals NHS Trust (GB)
Good health and well-being
Openalex Percentile: Top 14%
CNS Lymphoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon